ProMIS Neurosciences separates with COO Gavin Malenfant; position eliminated.

ProMIS Neurosciences Inc.

Gavin T. Malenfant separated as COO effective February 14, 2025.
Company terminated the COO role and will not replace Mr. Malenfant.
Severance benefits will be provided under a Separation Agreement referencing his employment contract.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gavin T. Malenfant

Chief Operating Officer

PMN · ProMIS Neurosciences Inc.

Effective: 2025-02-14
Filed: February 19, 2025, 6:59 PM ET

On February 14, 2025, ProMIS Neurosciences Inc. (the “Company”) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February 14, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gavin T. Malenfant departed as Chief Operating Officer at ProMIS Neurosciences Inc..

Action: separated
Role: Chief Operating Officer

Exact text from the filing

On February 14, 2025, ProMIS Neurosciences Inc. (the “Company”) separated with Gavin T. Malenfant as Chief Operating Officer of the Company, effective as of February 14, 2025

View on SEC.gov

ProMIS Neurosciences Inc. filing history →

Source: SEC EDGAR

accession 0001558370-25-001158

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.